Extended Depth-of-Focus Intraocular Lens Implantation in Patients with Age-Related Macular Degeneration: A Pilot Study

Purpose: To assess visual outcomes of the implantation of a non -diffractive extended depth of focus (EDOF) intraocular lens (IOL) in patients with age -related macular degeneration (AMD). Setting: Ophthalmology practice, Sydney, Australia. Design: Retrospective chart review. Methods: Patients with AMD undergoing cataract surgery and receiving non -diffractive EDOF AcrySof IQ Vivity IOL implantation over a 2 -year period were identified. Corrected distance visual acuity (CDVA), distance -corrected near visual acuity (DCNVA; 50 cm), contrast sensitivity, central foveal thickness, VF -14 questionnaire results, and quality of life where available were analyzed. Results: A total of 28 sequential patients (51 eyes) were included in this pilot study (46% male, mean age 77.4 years). Of 27 eyes that had late AMD, 17 (63%) had wet AMD. Mean patient preoperative CDVA was logMAR 0.32 +/- 0.29. Postoperative monocular CDVA and DCNVA were logMAR 0.20 +/- 0.25 and N9 +/- 5 (range N5-N36), respectively. Eyes achieving postoperative CDVA of Snellen 6/5-6/ 12 (n=42, 82%), 6/15-6/24 (n=7, 14%), and greater than 6/24 (n=2, 4%) achieved a mean DCNVA of N8 (range N5-N10), N13 (range N10-N18), and N27 (range N18-N36), respectively. Eyes achieving CDVA of Snellen 6/5-6/12 showed contrast sensitivity within the normal range. On postoperative VF -14 questionnaire, patients with CDVA of Snellen 6/5-6/12 reported minimal visual impairment, while patients with CDVA greater than 6/15 reported mild impairment. A majority of patients (96%, n=27) were satisfied with the improvement in quality of life postoperatively. No intraoperative complications were reported. Conclusion: The EDOF AcrySof IQ Vivity IOL provides improved near vision proportional to distance vision in patients with early AMD.